Dapafyzin-M 10/500 Tablet ER
Marketer
Care Formulation Labs Pvt Ltd
Salt Composition
Dapagliflozin (10mg) + Metformin (500mg)
Overview Dapafyzin-M 10/500 Tablet ER
Dapafyzin-M 10/500 Extended-Release tablets combine two medications to manage type 2 diabetes. This treatment helps regulate elevated blood glucose, lessening the risk of severe diabetic complications and contributing to heart health protection. Dapafyzin-M 10/500 ER can be taken with food; consistent daily dosing improves adherence. Dosage is determined by your physician; discontinuation requires medical consultation to avoid potentially dangerous blood sugar spikes and complications such as kidney disease or vision loss. This medication is a component of a comprehensive diabetes management plan, encompassing dietary adjustments, physical activity, and weight management as recommended by your doctor. Commonly reported side effects include pharyngitis, rhinitis, nasal congestion, cephalalgia, nausea, emesis, and diarrhea. Adequate hydration minimizes dehydration risk. Genital yeast infections are a possibility; diligent hygiene is preventative. Prior to commencing treatment, disclose any kidney or liver dysfunction, urinary tract infections, or diuretic use to your doctor. Pregnant or lactating individuals should seek medical advice. Limit alcohol consumption, as it might potentiate adverse effects. Regular blood glucose monitoring is crucial during treatment.
Primary Ingredients of Dapafyzin-M 10/500 Tablet ER
No information provided. Please provide the text you wish to be rephrased.
Uses of Dapafyzin-M 10/500 Tablet ER
Managing type 2 diabetes
Major Benefits of Dapafyzin-M 10/500 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Dapafyzin-M 10/500 Tablet ER whole; avoid chewing, crushing, or breaking it. Administer this extended-release tablet with a meal.
Common Side effects of Dapafyzin-M 10/500 Tablet ER:
- Nausea
- Vomiting
- Diarrhea
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
- Polyuria
- Flatulence
- Skin rash
- Taste change
- Difficulty in urination
- Hypoglycemia (low blood glucose level)
- Tremors
- Dizziness
- Back pain
- Increased hematocrit
- Decreased creatinine clearance
- Dyslipidemia
How to use Dapafyzin-M 10/500 Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Dapafyzin-M 10/500 Tablet ER whole; avoid chewing, crushing, or fracturing it. Administer this extended-release tablet with a meal.
How Dapafyzin-M 10/500 Tablet ER works:
Dapagliflozin and Metformin, combined as Dapafyzin-M 10/500 Extended-Release tablets, offer enhanced blood glucose management. Dapagliflozin facilitates urinary glucose excretion, while Metformin reduces hepatic glucose production, slows intestinal glucose uptake, and improves insulin sensitivity. This dual action leads to superior glycemic control.
SAFETY ADVICE
AlcoholUNSAFE
Combining Dapafyzin-M 10/500 Tablet ER with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Dapafyzin-M 10/500 Extended-Release tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible hazards prior to prescribing this medication. Seek medical advice before taking this medicine.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Dapafyzin-M 10/500 tablets are likely not suitable for use while breastfeeding. Available human data indicate potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with impaired kidney function should exercise caution when using Dapafyzin-M 10/500 Extended-Release tablets. Dosage modification may be necessary; physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should use Dapafyzin-M 10/500 Extended-Release tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Dapafyzin-M 10/500 Tablet ER :
Should you forget a Dapafyzin-M 10/500 Tablet ER dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Dapafyzin-M 10/500 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |


